Bionano Genomics, Inc.
NASDAQ:BNGO
0.2946 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -232.493 | -132.596 | -72.435 | -41.106 | -29.815 | -18.496 | -23.365 | -18.849 |
| Depreciation & Amortization
| 13.708 | 9.84 | 3.37 | 1.48 | 1.128 | 1.321 | 1.504 | 1.115 |
| Deferred Income Tax
| 8.441 | 1.76 | -5.777 | 1.935 | 1.9 | -2.459 | 0.479 | -3.006 |
| Stock Based Compensation
| 15.178 | 22.417 | 9.719 | 1.554 | 1.346 | 1.309 | 0.383 | 0.131 |
| Change In Working Capital
| -14.769 | -28.588 | -7.652 | -3.44 | -4.972 | -2.369 | 0.085 | -2.961 |
| Accounts Receivables
| -2.296 | -2.9 | -0.493 | 2.087 | -2.374 | -0.9 | -1.768 | -0.856 |
| Inventory
| -4.15 | -23.676 | -15.928 | -4.201 | -3.641 | -0.419 | -0.336 | -0.726 |
| Accounts Payables
| -1.995 | 1.949 | 6.781 | -1.809 | 1.362 | -0.954 | 1.541 | -0.609 |
| Other Working Capital
| -6.328 | -3.961 | 1.988 | 0.483 | -0.319 | -0.095 | 0.647 | -0.77 |
| Other Non Cash Items
| 80.233 | 2.351 | 0.848 | 1.264 | 0.883 | 0.75 | 0.097 | 0.074 |
| Operating Cash Flow
| -129.702 | -124.816 | -71.927 | -38.314 | -29.53 | -19.944 | -20.818 | -23.496 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -1.691 | -3.302 | -1.46 | 0 | -0.061 | -0.332 | -1.018 | -1.35 |
| Acquisitions Net
| 0.096 | -31.344 | -49.086 | -2.45 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -111.264 | -84.195 | -313.392 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 137.017 | 200.888 | 86.483 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 25.753 | 0.72 | -0.607 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 24.158 | 82.767 | -278.062 | -2.45 | -0.061 | -0.332 | -1.018 | -1.35 |
| Financing Activities: | ||||||||
| Debt Repayment
| -9.047 | -0.036 | -15.005 | -7.258 | -14.427 | -7.448 | 0 | -5 |
| Common Stock Issued
| 56.383 | 23.128 | 342.711 | 39.934 | 19.556 | 19.39 | 17.608 | 23.545 |
| Common Stock Repurchased
| 0 | 0 | 0 | -2 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 71 | -0.085 | 8.405 | 33.226 | 25.25 | 23.834 | 17.608 | 30.431 |
| Financing Cash Flow
| 118.336 | 23.007 | 336.111 | 61.902 | 30.379 | 35.776 | 17.608 | 25.431 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0.065 | -0.038 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 47.974 | -19.08 | -13.878 | 21.137 | 0.789 | 15.501 | -4.228 | 0.585 |
| Cash At End Of Period
| 53.065 | 5.491 | 24.571 | 38.449 | 17.311 | 16.523 | 1.022 | 5.25 |